Skip to menu Skip to content Skip to footer
News

Immune cell ‘atlas’ will help kids fight life-threatening diseases

6 September 2024
Two scientists in lab coats and goggles working in a lab.
Professor Di Yu with colleague Dr Emely Hernández in the lab.

Researchers at The University of Queensland are developing a comprehensive paediatric immune cell ‘atlas’ to aid in the diagnosis and treatment of children with life-threatening diseases such as cancer, diabetes and lupus.

Project lead and Director of the Ian Frazer Centre for Children’s Immunotherapy Research Professor Di Yu will collaborate with the Queensland Children’s Hospital to collect more than 1000 blood samples from a diverse group of children with healthy and abnormal immune systems.

“The diverse immune cells in these blood samples will be analysed using single-cell sequencing, which is the most advanced technology available to examine the function of individual cells,” Professor Yu said.

“This will help us establish a comprehensive paediatric immune normality reference, which we call an atlas.

“Once the mapping is complete, we can then compare blood samples from children with immune-related diseases to the atlas.”

Senior Research Fellow Dr Kelvin Tuong said that in autoimmune disease, the immune system produces antibodies that attack the body’s own cells, tissues and organs, resulting in inflammation and damage.  

“Conversely in cancer, the immune function becomes deficient to eliminate tumours,” Dr Tuong said.

“Our mapping will allow us to identify differences in immune cells in healthy children and those who are fighting disease.

“This knowledge will be invaluable in unlocking the secrets of the paediatric immune system to develop new immunotherapy treatments for life-threatening conditions such as cancer, diabetes and lupus.”

It is hoped that the 5-year project will also develop a user-friendly software to allow the atlas to be used by clinicians across Australia and around the world.

“This platform will empower healthcare professionals to tailor treatment plans for children, maximising therapeutic benefits while minimising long-term side effects,” Dr Tuong said.

The Ian Frazer Centre for Children’s Immunotherapy Research at the UQ Child Health Research Centre was established in 2022 with funding support from Children’s Hospital Foundation and The University of Queensland.

The $7 million project has received funding from the Medical Research Future Fund (MRFF), Children’s Hospital Foundation, the Australian National University and Sanofi.

Partner organisations include Children’s Health Queensland, Pathology Queensland, QIMR Berghofer, Queensland Cyber Infrastructure Foundation, Sanofi, The Australian National University and Children’s Cancer Institute.

 

Media contact

UQ Faculty of Medicine Media 
med.media@uq.edu.au
+61 436 368 746

Related articles

Close up of two young men facing each other

Nature versus nurture question addressed in landmark study

Genome sequencing has been used to determine how much genes influence human characteristics including height and weight, and susceptibility to diseases like Type 2 diabetes, in a study co-led by UQ researchers and collaborators at genomic technology company Illumina, Inc.
13 November 2025
Female doctor taking blood pressure of female patient in clinic.

A better way to assess cardiovascular health

Lower body mass index (BMI), blood pressure and cholesterol were not always the most important factors when considering a person’s overall risk of dying, University of Queensland research has concluded.
10 November 2025

Media contact

Subscribe to UQ News

Get the latest from our newsroom.